APA (7th ed.) Citation

M, P., S, Y., IM, L., SL, P., K, R., RE, L., . . . DJ, B. (2005). Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatric Diabetes, 6(4), 184. https://doi.org/10.1111/j.1399-543x.2005.00127.x

Chicago Style (17th ed.) Citation

M, Pietropaolo, et al. "Cytoplasmic Islet Cell Antibodies Remain Valuable in Defining Risk of Progression to Type 1 Diabetes in Subjects with Other Islet Autoantibodies." Pediatric Diabetes 6, no. 4 (2005): 184. https://doi.org/10.1111/j.1399-543x.2005.00127.x.

MLA (9th ed.) Citation

M, Pietropaolo, et al. "Cytoplasmic Islet Cell Antibodies Remain Valuable in Defining Risk of Progression to Type 1 Diabetes in Subjects with Other Islet Autoantibodies." Pediatric Diabetes, vol. 6, no. 4, 2005, p. 184, https://doi.org/10.1111/j.1399-543x.2005.00127.x.